JOURNAL ARTICLE
Risk factors for gestational trophoblastic neoplasia development of singleton normal fetus with partial hydatidiform mole pregnancy: A retrospective cohort and literature review.
Published In: Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 2. P. 479 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Zhong, Lan; Song, Liang; Yin, Rutie; Li, Qingli; Wang, Danqing 3 of 3
Abstract
Introduction: Singleton normal fetus with partial hydatidiform mole (PHM) pregnancy is a rare phenomenon. No previous reports have investigated the risk factors of gestational trophoblastic neoplasia (GTN) progression following this condition. Methods: We retrospectively enrolled cases of singleton normal fetuses with PHM pregnancies at West China Second University Hospital, Sichuan University, from 2005 to 2017. Other cases were identified from PubMed databases during 1975 to 2021 for the cohort study. Cox proportional hazards models were applied to evaluate risk factors for GTN progression based on the patient's clinical characteristics. Results: Overall, 36 cases of singleton normal fetuses with PHM pregnancies were enrolled. After a median follow‐up of 4.0 (0.8–12.0) months, nine (25.0%) patients progressed to GTN. Gestational age at pregnancy termination (hazard ratio [HR] 0.88; 95% confidence interval [CI] 0.78–0.99, p = 0.032), hyperthyroidism (HR 5.75; 95% CI, 1.16–28.50, p = 0.032), and reasons for pregnancy termination (medical indications vs. patients' choice; HR 0.25; 95% CI, 0.06–0.99, p = 0.049) were significantly correlated with GTN progression. Area under the receiver operating characteristic curve (AUC) of gestational age at pregnancy termination to predict non‐progression to GTN was 0.784 (95% CI, 0.615–0.903, p < 0.001). A clinically significant cutoff value, that is, gestational age of 24 weeks, was determined by comprehensively considering the cutoff values of AUC and clinical significance of gestational age. Conclusions: Compared to gestational age of pregnancy termination <24 weeks, ≥24 weeks was a protective factor for GTN. Therefore, there is enough evidence to continue pregnancy, except for uncontrolled severe complications, without increasing the risk of GTN progression. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:Journal of Obstetrics & Gynaecology Research. 2023/02, Vol. 49, Issue 2, p479
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2023
- ISSN:1341-8076
- DOI:10.1111/jog.15488
- Accession Number:161758091
- Copyright Statement:Copyright of Journal of Obstetrics & Gynaecology Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.